Dr Reddy's Laboratories Shares Outstanding 2010-2024 | RDY

Dr Reddy's Laboratories shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Dr Reddy's Laboratories shares outstanding for the quarter ending June 30, 2024 were 0.167B, a 2.34% decline year-over-year.
  • Dr Reddy's Laboratories 2024 shares outstanding were 0.167B, a 0.19% increase from 2023.
  • Dr Reddy's Laboratories 2023 shares outstanding were 0.166B, a 0.03% increase from 2022.
  • Dr Reddy's Laboratories 2022 shares outstanding were 0.166B, a 0.01% increase from 2021.
Dr Reddy's Laboratories Annual Shares Outstanding
(Millions of Shares)
2024 167
2023 166
2022 166
2021 166
2020 166
2019 166
2018 166
2017 167
2016 171
2015 170
2014 171
2013 171
2012 176
2011 165
2010 240
2009 170
Dr Reddy's Laboratories Quarterly Shares Outstanding
(Millions of Shares)
2024-06-30 167
2024-03-31 167
2023-12-31 167
2023-09-30 167
2023-06-30 171
2023-03-31 166
2022-12-31 166
2022-09-30 166
2022-06-30 167
2022-03-31 166
2021-12-31 166
2021-09-30 166
2021-06-30 167
2021-03-31 166
2020-12-31 169
2020-09-30 166
2020-06-30 167
2020-03-31 166
2019-12-31 166
2019-09-30 166
2019-06-30 166
2019-03-31 166
2018-12-31 166
2018-09-30 166
2018-06-30 168
2018-03-31 166
2017-12-31 166
2017-09-30 166
2017-06-30 150
2017-03-31 167
2016-12-31 166
2016-09-30 166
2016-06-30 173
2016-03-31 171
2015-12-31 171
2015-09-30 171
2015-06-30 169
2015-03-31 169
2014-12-31 172
2014-09-30 172
2014-06-30 170
2014-03-31 170
2013-12-31 169
2013-09-30 169
2013-06-30 153
2013-03-31 175
2012-12-31 173
2012-09-30 154
2012-06-30 150
2012-03-31 170
2011-12-31 162
2011-09-30 158
2011-06-30 169
2011-03-31 188
2010-12-31 153
2010-09-30 160
2010-06-30 150
2010-03-31 185
2009-12-31 160
2009-09-30 150
2009-06-30 169
2009-03-31 175
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $12.399B $3.350B
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00